1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US: Year-over-year growth 2024-2029 (%)
- Data Table on US: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Multiple Sclerosis Market in US 2019 - 2023
- Historic Market Size - Data Table on Multiple Sclerosis Market in US 2019 - 2023 ($ billion)
- 5.2 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6.1 Impact of AI on Multiple Sclerosis Market in US
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Route of Administration
- 8.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- 8.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 8.3 Parenteral - Market size and forecast 2024-2029
- Chart on Parenteral - Market size and forecast 2024-2029 ($ billion)
- Data Table on Parenteral - Market size and forecast 2024-2029 ($ billion)
- Chart on Parenteral - Year-over-year growth 2024-2029 (%)
- Data Table on Parenteral - Year-over-year growth 2024-2029 (%)
- 8.4 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ billion)
- Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ billion)
- Data Table on Market opportunity by Route of Administration ($ billion)
9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 Biologics - Market size and forecast 2024-2029
- Chart on Biologics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Biologics - Market size and forecast 2024-2029 ($ billion)
- Chart on Biologics - Year-over-year growth 2024-2029 (%)
- Data Table on Biologics - Year-over-year growth 2024-2029 (%)
- 9.4 Small molecules - Market size and forecast 2024-2029
- Chart on Small molecules - Market size and forecast 2024-2029 ($ billion)
- Data Table on Small molecules - Market size and forecast 2024-2029 ($ billion)
- Chart on Small molecules - Year-over-year growth 2024-2029 (%)
- Data Table on Small molecules - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Drivers, Challenges, and Opportunity/Restraints
- 11.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 11.4 Market opportunities/restraints
12 Competitive Landscape
- 12.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 12.3 Landscape disruption
- Overview on factors of disruption
- 12.4 Industry risks
- Impact of key risks on business
13 Competitive Analysis
- 13.2 Company ranking index
- 13.3 Market positioning of companies
- Matrix on companies position and classification
- 13.4 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 13.5 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
- 13.6 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- 13.7 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 13.8 Johnson and Johnson Inc.
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key news
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Segment focus
- SWOT
- 13.9 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 13.10 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 13.11 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- 13.12 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT
- 13.13 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT
14 Appendix
- 14.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 14.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 14.4 Research methodology
- 14.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 14.9 360 degree market analysis
- 360 degree market analysis
- 14.10 List of abbreviations
Get the report (PDF) sent to your email within minutes.